Search

Your search keyword '"Vandenberghe, R."' showing total 945 results

Search Constraints

Start Over You searched for: Author "Vandenberghe, R." Remove constraint Author: "Vandenberghe, R."
945 results on '"Vandenberghe, R."'

Search Results

1. Longitudinal cerebral perfusion in presymptomatic genetic frontotemporal dementia: GENFI results

2. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (Nature Communications, (2021), 12, 1, (3417), 10.1038/s41467-021-22491-8)

3. Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementia

4. New insights into the genetic etiology of Alzheimer's disease and related dementias

5. Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales

6. Prodromal language impairment in genetic frontotemporal dementia within the GENFI cohort

18. Modelling the cascade of biomarker changes in GRN-related frontotemporal dementia

19. Orienting to different dimensions of word meaning alters the representation of word meaning in early processing regions.

20. Data-driven staging of genetic frontotemporal dementia using multi-modal MRI

21. New insights into the genetic etiology of Alzheimer's disease and related dementias

22. Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease (vol 17, pg 1, 2022)

23. The Evaluation Practice of Teachers as a Learning Opportunity for Students.

27. LifeTime and improving European healthcare through cell-based interceptive medicine

29. Practice effects in genetic frontotemporal dementia and at-risk individuals: a GENFI study

30. TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels

31. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

32. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

33. Publisher Correction: LifeTime and improving European healthcare through cell-based interceptive medicine (Nature, (2020), 587, 7834, (377-386), 10.1038/s41586-020-2715-9)

34. Progression of Behavioral Disturbances and Neuropsychiatric Symptoms in Patients With Genetic Frontotemporal Dementia

35. Disease-related cortical thinning in presymptomatic granulin mutation carriers

36. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

37. Progression of Behavioral Disturbances and Neuropsychiatric Symptoms in Patients With Genetic Frontotemporal Dementia

38. 1st Conference Clinical Trials on Alzheimer’s Disease September 17-18-19, 2008 School of Medecine Montpellier, France

40. Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset

41. Analysis of brain atrophy and local gene expression in genetic frontotemporal dementia

42. Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study

45. The European Reference Network for Rare Neurological Diseases

46. Apathy in presymptomatic genetic frontotemporal dementia predicts cognitive decline and is driven by structural brain changes

47. Social cognition impairment in genetic frontotemporal dementia within the GENFI cohort

48. LifeTime and improving European healthcare through cell-based interceptive medicine

49. Value of FDG-PET as a supporting biomarker for dementia with Lewy bodies at stages of early dopaminergic loss

50. Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study

Catalog

Books, media, physical & digital resources